China Pharma Holdings, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $16.5M
Liabilities Breakdown FY2023
Total Liabilities: $9.0M
Asset Breakdown
Total Assets: $16.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.4M | 8.6% |
| Accounts Receivable | $504.4K | 3.1% |
| Inventory | $3.7M | 22.7% |
| Property, Plant & Equipment | $7.1M | 43.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $3.3M | 19.8% |
| Other Assets | $452.7K | 2.7% |
Liabilities Breakdown
Total Liabilities: $9.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $966.4K | 10.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $8.0M | 89.3% |